tetano
Editor, Senior Moderator
Inflamm Bowel Dis
. 2023 Feb 15;izad019.
doi: 10.1093/ibd/izad019. Online ahead of print.
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Freddy Caldera[SUP] 1 [/SUP], Luke Richard[SUP] 2 [/SUP], Mazen Almasry[SUP] 2 [/SUP], Hiep Phan[SUP] 2 [/SUP], Kelly Chun[SUP] 3 [/SUP], Francis A Farraye[SUP] 4 [/SUP], Mary S Hayney[SUP] 5 [/SUP]
Affiliations
No abstract availableKeywords: COVID-19 vaccine; Crohn’s disease; inflammatory bowel disease; ulcerative colitis.
Plain language summary
We evaluated antibody concentrations 6 months after a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. Almost all patients had an antibody response, and those with a previous SARS-CoV-2 infection had higher antibody concentrations.
. 2023 Feb 15;izad019.
doi: 10.1093/ibd/izad019. Online ahead of print.
Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Freddy Caldera[SUP] 1 [/SUP], Luke Richard[SUP] 2 [/SUP], Mazen Almasry[SUP] 2 [/SUP], Hiep Phan[SUP] 2 [/SUP], Kelly Chun[SUP] 3 [/SUP], Francis A Farraye[SUP] 4 [/SUP], Mary S Hayney[SUP] 5 [/SUP]
Affiliations
- PMID: 36788133
- DOI: 10.1093/ibd/izad019
No abstract availableKeywords: COVID-19 vaccine; Crohn’s disease; inflammatory bowel disease; ulcerative colitis.
Plain language summary
We evaluated antibody concentrations 6 months after a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. Almost all patients had an antibody response, and those with a previous SARS-CoV-2 infection had higher antibody concentrations.